Naveris develops highly sensitive blood tests, liquid biopsies, that identify viral cancers significantly earlier than is possible with scans or traditional biopsies.
Transformative Technologies for Early Cancer Detection.
Identifying viral cancers
earlier than ever before.
Learn More
Optimize HPV+ cancer surveillance with NavDx.
Our Core Technology
Our mission at Naveris is to deliver disruptive technology with the potential to transform cancer detection and improve patient outcomes.
Highly Sensitive Blood Tests
Find cancers faster and easier with non-invasive liquid biopsies.
Transform Cancer Detection
Real-time monitoring of response in patients undergoing treatment.
Improve Patient Outcomes
Detection of cancer recurrence for patients in remission.